ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Immunotherapy cancer drugs cleared by FDA – Bangkok Post

Bangkok PostImmunotherapy cancer drugs cleared by FDABangkok PostThree drugs in the immunotherapy class have been approved by the Food and Drug Administration (FDA) to be used for treating cancer. Assoc Prof Narin Voravud from the Chulalongkorn Univers… Continue reading

2017-01-28 Michael Zand NEWS

Dr. Sklar on Immunotherapy Potential in Bladder Cancer – OncLive

OncLiveDr. Sklar on Immunotherapy Potential in Bladder CancerOncLiveLooking ahead to the future, Sklar says that patients who have had very little or no hope thus far can likely see more benefits if they are treated with immunotherapy. The next steps s… Continue reading

2017-01-28 Michael Zand NEWS

As city elections heat up, Kriseman’s St. Pete vision contrasts Trump – Creative Loafing Tampa

Continue reading

2017-01-28 Michael Zand NEWS

Paralyzed patients regain hand, arm function in stem cell clinical trial – Becker’s Hospital Review

Paralyzed patients regain hand, arm function in stem cell clinical trialBecker’s Hospital ReviewAn experimental stem cell therapy has helped paralyzed patients regain function in their arms, hands and fingers. The innovative therapy involves injecting … Continue reading

2017-01-27 Michael Zand NEWS

TraCS helps fund UNC researcher to deliver cancer immunotherapy – Translational Research Newsroom (blog)


Creative Loafing Tampa

As city elections heat up, Kriseman’s St. Pete vision contrasts Trump
Creative Loafing Tampa
Kriseman in New York City Friday, “bummed” that he wasn’t able to go to Trump tower.Are you a Democrat? If yes, then how are you not in hibernation by now, given that we’re between presidential election years? Or whatever state of suspended animation …

Continue reading

2017-01-27 Michael Zand NEWS

Innovation: Stem Cells For Shoulder Injuries – SDPB Radio

SDPB RadioInnovation: Stem Cells For Shoulder InjuriesSDPB RadioResearchers at Sanford Health want to know whether stems cells from abdominal fat can help with shoulder injuries. An FDA-approved trial is in the works with 18 patients between Sioux Fall… Continue reading

2017-01-27 Michael Zand NEWS

Combo Therapy After Stem Cell Transplant Improves Survival in Myeloma Patients, Trial Finds – Myeloma Research News


Translational Research Newsroom (blog)

TraCS helps fund UNC researcher to deliver cancer immunotherapy
Translational Research Newsroom (blog)
UNC, NCSU biomedical engineering research team’s findings show that engineered platelets can deliver antibodies to kill cancer cells before they can grow or spread elsewhere in the body. CHAPEL HILL, NC – After surgery to remove a cancerous tumor …

Continue reading

2017-01-27 Michael Zand NEWS

New system for therapeutic gene delivery increases transgene expression up to 100-fold – EurekAlert (press release)

EurekAlert (press release)New system for therapeutic gene delivery increases transgene expression up to 100-foldEurekAlert (press release)New Rochelle, NY, Jan. 27, 2017 — Advanced engineering of a mini-intronic plasmid (MIP) system designed to carry … Continue reading

2017-01-27 Michael Zand NEWS
  • 1
  • …
  • 2,168
  • 2,169
  • 2,170
  • 2,171
  • 2,172
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Myeloma Research News

Combo Therapy After Stem Cell Transplant Improves Survival in Myeloma Patients, Trial Finds
Myeloma Research News
The standard care for younger patients with newly diagnosed myeloma is treatment with high-dose Alkeran (melphalan) followed by a transplant with the patient’s own stem cells (autologous stem cell transplant, or ASCT). But most patients relapse after …